BEAT: A multicenter, doubled-blind, randomized, placebo-controlled, Phase 3 study to assess the efficacy and safety of oral BPS-314d-MR Added-on to treprostinil, inhaled (Tyvaso ?) in subjects with pulmonary arterial hypertension